Coredio Patents

Patent portfolio assigned to Coredio (verified via public assignee records). Mountain View healthcare AI (founded 2023); non-invasive heart-failure hemodynamic assessment (CPSE), FDA Breakthrough Device Designation March 2026. Holds exclusive patent rights licensed from Rochester Institute of Technology (per press) -> has_patents true (licensed). No named customers (early/pre-510k)